What I hate most about these boards is that people call

New Post Public Reply Private Reply Replies (2) Message Board
LivingTheGoodLife
677
What I hate most about these boards is that people call people idiots, A-holes, swear, and pretty much talk smack, but few post usable or traceable DD, so people can do their own DD on what is presented. I wish people would look at what has already been presented as DD and do their own research and find out about this company.

Right now, it is just a symbol, because the company has decided it isn't ready to release what is needed to get this holding company moving on it's road to NASDAQ. IMHO, they are still trying to equip themselves with what they need to apply with the SEC, to meet the requirements to uplist and to report correctly so they can list on NASDAQ, and stay current and file on time. This company has chosen to remain quite until they are ready to release all of their major information. That alone tells me that this company is real. Any scam company would behave totally different than this one.

When they iron out everything, I am sure they will start doing what they need to do to reach NASDAQ, remain current and stay transparent as required by such a listing.

This was an R&D company in 2015, part of ZJMY was merged into DOLV, in the early part of 2017, but the major portion of ZJMY was held in another private company until FINRA approved the name change to JBZY. That portion was not merged into JBZY until November, 2017, which is what will be revealed on the Annual Consolidated Financial Report.

If you don't believe in this company, please sell and move on, or do what you need to do to stay sane. Complaining or belittling others doesn't help your mental state. If you believe in this company, try to stay positive. There are people here that play the shorting game to try to make some money and those are the forces at work right now because of the lack of news and the low volume. Based upon the large sales that have appeared the last few days, IMHO, there are a few longs that have decided to bale. I say this because the float is very tight and large sales don't usually happen when the float is tight. Some will say that that is dilution, but I don't buy that because there are people buying any shares that people wish to sell. That tells me that people believe in their DD and large bids are not usually placed by newbies.

Sorry, but you will have to be patient, like the rest of us, until the financials come out and the rest of the story is revealed. Yeah, you might say "they will never come out", but if you look back over the last few filings of this company, you will see that they have all been late. Seeing that this might hold more than was revealed in the prior financial reports, IMHO, this may take a little more time than the previous financials.

You can take what I have said any way you want, since I am a major long.

GLTY and all the longs.

JB&ZJMY Holding Company Inc (JBZY) Stock Research Links

JBZY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 10

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Cookie Storage Solution Enhances Baking Experience

Updated Category News Views 311

Innovative Cookie Storage & Cooling Solution In the realm of baking, having the right tools can make all the difference, especially when it comes to cooling and storing cookies. An inventive individual from New Kent faced frustrations while trying to manage space during the festive baking period. Realizing the need for a solution, this inventor developed the SHERIS COOKIE...

Continue Reading
Alarum Technologies Securities Class Action Update and Analysis

Updated Category News Views 122

Understanding Alarum Technologies Securities Class Action Investors of Alarum Technologies Ltd. (NASDAQ: ALAR) may be facing a significant turning point regarding their investments. A class action lawsuit has been initiated concerning the actions of the company during a specified period. Those affected during this critical time frame have important rights and potential...

Continue Reading
TransCode Therapeutics Schedules Adjourned Special Meeting Updates

Updated Category News Views 211

TransCode Therapeutics Provides Updates on Adjourned Special Meeting TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has announced the adjournment of its Special Meeting, originally scheduled to gather shareholder votes on critical proposals. The meeting will now take place virtually on May 2, allowing shareholders to participate in a flexible and accessible format. The delay...

Continue Reading
Understanding Rep. Mike Kelly's Recent Union Pacific Stock Trading

Updated Category News Views 219

Understanding Rep. Mike Kelly's Recent Stock Activity Recently filed disclosures reveal that Representative Mike Kelly took part in a noteworthy transaction involving Union Pacific, valued between $15,001 and $50,000. This filing was made on December 12, 2024, highlighting the ongoing stock activities of congressional members. As of now, the share price for Union Pacific...

Continue Reading
Cohen & Steers Fund Details: Distribution and Returns Overview

Updated Category News Views 84

Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) stirred the pot back in 2024 when it laid out its managed distribution policy to bolster returns and maintain shareholder interest. The monthly distributions, set at a fixed rate per common share, aimed to give investors a reliable income stream while capitalizing on various investment opportunities throughout the...

Continue Reading